A detailed history of Captrust Financial Advisors transactions in Conmed Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 6,251 shares of CNMD stock, worth $439,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,251
Previous 5,087 22.88%
Holding current value
$439,820
Previous $352,000 27.56%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.09 - $76.92 $74,600 - $89,534
1,164 Added 22.88%
6,251 $449,000
Q2 2024

Aug 14, 2024

BUY
$61.9 - $80.36 $15,598 - $20,250
252 Added 5.21%
5,087 $352,000
Q1 2024

May 15, 2024

SELL
$75.36 - $112.51 $99,098 - $147,950
-1,315 Reduced 21.38%
4,835 $387,000
Q4 2023

Feb 14, 2024

BUY
$91.3 - $115.05 $181,230 - $228,374
1,985 Added 47.66%
6,150 $673,000
Q3 2023

Nov 14, 2023

BUY
$97.55 - $135.91 $212,171 - $295,604
2,175 Added 109.3%
4,165 $420,000
Q2 2023

Aug 14, 2023

BUY
$102.55 - $136.38 $204,074 - $271,396
1,990 New
1,990 $270,000
Q2 2022

Aug 23, 2022

SELL
$88.23 - $154.18 $5,911 - $10,330
-67 Reduced 3.59%
1,800 $173,000
Q2 2022

Aug 16, 2022

BUY
$88.23 - $154.18 $10,499 - $18,347
119 Added 6.81%
1,867 $179,000
Q1 2022

May 16, 2022

BUY
$121.88 - $150.0 $104,694 - $128,850
859 Added 96.63%
1,748 $260,000
Q4 2021

Feb 14, 2022

SELL
$129.86 - $157.03 $44,671 - $54,018
-344 Reduced 27.9%
889 $126,000
Q3 2021

Nov 16, 2021

BUY
$122.87 - $139.12 $5,529 - $6,260
45 Added 3.79%
1,233 $162,000
Q2 2021

Aug 16, 2021

SELL
$128.08 - $145.09 $3,714 - $4,207
-29 Reduced 2.38%
1,188 $164,000
Q1 2021

May 17, 2021

BUY
$111.35 - $130.59 $107,675 - $126,280
967 Added 386.8%
1,217 $159,000
Q4 2020

Feb 16, 2021

BUY
$77.7 - $112.82 $5,827 - $8,461
75 Added 42.86%
250 $28,000
Q3 2020

Nov 17, 2020

BUY
$69.87 - $89.2 $12,227 - $15,610
175 New
175 $14,000

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.14B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.